Практические рекомендации по кислородотерапии и респираторной поддержке пациентов с COVID-19 на дореанимационном этапе

Острая дыхательная недостаточность (ОДН) является ведущей причиной смерти пациентов с тяжелыми формами COVID-19, госпитализированных в стационары. Традиционно считалось, что при тяжелой пневмонии, осложненной ОДН, выживаемость способно повысить раннее использование у пациентов интубации и искусственной вентиляции легких (ИВЛ). Однако по данным недавно опубликованных исследований, при COVID-19 отмечается очень высокая летальность среди пациентов, получающих ИВЛ. В случае раннего (на дореанимационном этапе) начала кислородотерапии и респираторной поддержки у пациентов с COVID-19 снижается необходимость перевода в отделение реанимации, интубации трахеи и ИВЛ, и, следовательно, улучшается прогноз. В данной статье представлены практические рекомендации по кислородотерапии и респираторной поддержке на дореанимационном этапе у пациентов с коронавирусной инфекцией, осложненной развитием ОДН. 

1. World Health Organization. Global surveillance for human infection with coronavirus disease (COVID-2019). 2020. Available at: https://www.who.int/publications-detail/globalsurveillance-for-human-infection-with-novel-coronavirus- (2019-ncov) [Accessed: May 17, 2020].

2. Spina S., Marrazzo F., Migliari M. et al. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet. 2020; 395 (10227): Е49–50. DOI: 10.1016/S0140-6736(20)30493-1.

3. Глыбочко П.В., Фомин В.В., Авдеев С.Н. и др. Кли - ническая характеристика 1007 больных тяжелой SARSCoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клиническая фармакология и терапия. 2020; 29 (2): 21–29.

4. Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46 (5): 846–848. DOI: 10.1007/s00134-020-05991-x.

5. Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323 (20): 2052–2059. DOI: 10.1001/jama.2020.6775.

6. Zhu N., Zhang D., Wang W. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382: 727–733. DOI: 10.1056/NEJMoa2001017.

7. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. DOI: 10.1016/S0140-6736(20)30183-5.

8. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239–1242. DOI: 10.1001/jama.2020.2648.

9. Xie J., Covassin N., Fan Z. et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin. Proc. 2020; 95 (6): 1138–1147. DOI: 10.1016/j.mayocp.2020.04.006.

10. Bellani G., Laffey J.G., Pham T. et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am. J. Respir. Crit. Care Med. 2017; 195 (1): 67–77. DOI: 10.1164/rccm.201606-1306OC.

11. ICNARC. ICNARC report on COVID-19 in critical care. 10 April 2020.

12. Vitacca M., Nava S., Santus P., Harari S. Early consensus management for non-ICU acute respiratory failure SARSCoV-2 emergency in Italy: from ward to trenches. Eur. Respir. J. 2020; 55 (5): 2000632. DOI: 10.1183/13993003.00632-2020.

13. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382: 1708–1720. DOI: 10.1056/NEJMoa2002032.

14. Siemieniuk R.A.C., Cu D.K., Kim L.H. et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. Br. Med. J. 2018; 363: k4169. DOI: 10.1136/bmj.k4169.

15. Avdeev S.N., Aisanov Z.R., Chuchalin A.G. Compliance as a critical issue in long-term oxygen therapy. Monaldi. Arch. Chest Dis. 1999; 54 (1): 61–66.

16. Авдеев С.Н. Ургентная кислородотерапия. Вестник анестезиологии и реаниматологии. 2011; 8 (3): 42–51.

17. Авдеев С.Н. Современные рекомендации по неотложной кислородотерапии. Терапевтический архив. 2012; 84 (12): 108–114.

18. Anthonisen N.R. Hypoxemia and O2 therapy. Am. Rev. Res - pir. Dis. 1982; 126 (4): 729–733.

19. O′Driscoll B.R., Howard L.S., Earis J. et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017; 72 (Suppl. 1): ii1–90. DOI: 10.1136/thoraxjnl-2016-209729.

20. Alhazzani W., Møller M.H., Arabi Y.M. et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit. Care Med. 2020; 48 (6): e440–469. DOI: 10.1097/CCM.0000000000004363.

21. Berlin D.A., Gulick R.M., Martinez F.J. Severe Covid-19. N. Engl. J. Med. 2020; May 15. DOI: 10.1056/NEJMcp2009575.

22. Schacter E.N., Littner M.R., Luddy P., Beck G.J. Monitoring of oxygen delivery systems in clinical practice. Crit. Care Med. 1980; 8 (7): 405–409. DOI: 10.1097/00003246-198007000-00010.

23. Becker H.F., Polo O., McNamara S.G. et al. Effect of different levels of hyperoxia on breathing in healthy subjects. J. Appl. Physiol. 1996; 81 (4): 1683–1690. DOI: 10.1152/jappl.1996.81.4.1683.

24. Gibson R.L., Comer P.B., Beckham R.W., McGraw C.P. Actual transtracheal oxygen concentrations with commonly used oxygen equipment. Anesthesiology. 1976; 44 (1): 71–73. DOI: 10.1097/00000542-197601000-00019.

25. Cooper N. Acute medicine: Treatment with oxygen. Student Br. Med. J. 2004; 12: 56–58.

26. O'Connor M., Hall J.B., Schmidt G.A. et al. Acute hypo - xemic respiratory failure. In: Hall J.B., Schmidt G.A., Wood L.D.H., eds. Principles of Critical Care. New York: McGraw-Hill Publishers; 1998: 537–559.

27. Hare A. High-flow nasal cannula therapy in adults. Clin. Pulm. Med. 2017; 24: 95–104.

28. Mauri T., Turrini C., Eronia N. et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am. J. Respir. Crit. Care Med. 2017; 195: 1207–1215.

29. Nishimura M. High-flow nasal cannula oxygen therapy in adults. J. Intensive Care. 2015; 3 (1): 15. DOI: 10.1186/s40560-015-0084-5.

30. Helviz Y., Einav S. A systematic review of the high-flow nasal cannula for adult patients. Crit. Care. 2018; 22 (1): 71. DOI: 10.1186/s13054-018-1990-4.

31. Ou X., Hua Y., Liu J. et al. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. Can. Med. Assoc. J. 2017; 189 (7): E260–267. DOI: 10.1503/cmaj.160570.

32. Lambertsen C.J., Stroud M.W. III, Gould R.A. et al. Oxygen toxicity: respiratory responses of normal men to inhalation of 6 and 100 per cent oxygen under 3.5 atmospheres pressure. J. Appl. Physiol. 1953; 5 (9): 487–493. DOI: 10.1152/jappl.1953.5.9.487.

33. Lane R., Cockcroft A., Adams L., Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin. Sci. (Lond.) 1987; 72: 693–698.

34. Rochwerg B., Brochard L., Elliott M.W. et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur. Respir. J. 2017; 50 (2): 1602426. DOI: 10.1183/13993003.02426-2016.

35. Авдеев С.Н. Неинвазивная вентиляция легких при острой дыхательной недостаточности: от клинических рекомендаций – к реальной клинической практике. Комментарий к Клиническим рекомендациям по применению неинвазивной вентиляции легких при острой дыхательной недостаточности. Пульмонология. 2018; 28 (1): 32–35. DOI: 10.18093/0869-0189-2018-28-1-32-35.

36. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, 25 January 2020. Available at: https://apps.who.int/iris/handle/10665/330854 [Accessed: May 17, 2020].

37. World Federation of Societies of Anaesthesiologists. Coronavirus – guidance for anaesthesia and perioperative care providers. Available at: https://www.wfsahq.org/resources/coronavirus [Accessed: May 17, 2020].

38. The Faculty of Intensive Care Medicine. Letter regarding the Use of Continuous Positive Airway Pressure (CPAP) for COVID-19 positive patients / The Faculty of Intensive Care Medicine [Internet]. Available at: https://www.ficm.ac.uk/news-events-education/news/letter-regarding-use-continuouspositive-airway-pressure-cpap-covid-19 [Accessed: May 17, 2020].

39. Wang D., Hu B., Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061–1069. DOI: 10.1001/jama.2020.1585.

40. Li H.C., Ma J., Zhang H. et al. [Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43 (5): 396–400. DOI: 10.3760/cma.j.cn112147-20200312-00320 (in Chinese).

41. Авдеев С.Н. Неинвазивная вентиляция легких у пациентов c хронической обструктивной болезнью легких в стационаре и домашних условиях. Пульмонология. 2017; 27 (2): 232–249. DOI: 10.18093/0869-0189-2017-27-2-232-249.

42. Авдеев С.Н. Неинвазивная вентиляция легких при острой дыхательной недостаточности. Пульмонология. 2005; (6): 37–54.

43. Branson R.D., Chatburn R.L. Technical description and classification of modes of ventilator operation. Respir. Care. 1992; 37 (9): 1026–1044.

44. Cane R.D., Shapiro B.A. Mechanical ventilatory support. JAMA. 1985; 254 (1): 87–92.

45. Antonelli M., Conti G., Esquinas A. et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit. Care Med. 2007; 35 (1): 18–25.

46. Rana S., Jenad H., Gay P.C. et al. Failure of non-invasive ventilation in patients with acute lung injury: observational cohort study. Crit. Care. 2006; 10 (3): R79. DOI: 10.1186/cc4923.

47. Antonelli M., Conti G., Pelosi P. et al. New treatment of acute hypoxemic respiratory failure: noninvasive pressure support ventilation delivered by helmet – a pilot controlled trial. Crit. Care Med. 2002; 30 (3): 602–608. DOI: 10.1097/00003246-200203000-00019.

48. Squadrone V., Coha M., Cerutti E. et al. Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA. 2005; 293 (5): 589–595. DOI: 10.1001/jama.293.5.589.

49. Pfeifer M., Ewig S., Voshaar T. et al. Positionspapier zur praktischen Umsetzung der apparativen Differenzial - therapie der akuten respiratorischen Insuffizienz bei COVID-19. Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. (DGP). Pneumologie. 2020; April 22 (Published online). DOI: 10.1055/a-1157-9976.

50. Ferguson N., Fan E., Camporota L. et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012; 38 (10): 1573–1582. DOI: 10.1007/s00134-012-2682-1.

51. Specialty guides for patient management during the coronavirus pandemic. Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 (confirmed or suspected). 6 April 2020, Version 3 (Pub - lications approval reference: 001559). Available at: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-NIV-respiratory-support-andcoronavirus-v3.pdf [Accessed: May 17, 2020].

52. Lyons C., Callaghan M. The use of high-flow nasal oxygen in COVID-19. Anaesthesia. 2020; 75 (7): 843–847. DOI: 10.1111/anae.15073.

53. ANZICS. The Australian and New Zealand Intensive Care Society COVID-19 Guidelines. Version 1 (16 March 2020). Available at: www.anzics.com.au/wp-content/uploads/2020/03/ANZICS-COVID-19-Guidelines-Version-1.pdf [Accessed: May 25, 2020].

54. Alhazzani W., Møller M.H., Arabi Y.M. et al. Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Available at: www.esicm.org/wp-content/uploads/2020/03/SSC-COVID19-GUIDELINES.pdf [Accessed: May 25, 2020].

55. Ferioli M., Cisternino C., Leo V. et al. Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur. Respir. Rev. 2020; 29 (155): 200068 DOI: 10.1183/16000617.0068-2020.

56. Munshi L., Del Sorbo L., Adhikari N.K.J. et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann. Am. Thorac. Soc. 2017; 14 (Suppl. 4): S280–288. DOI: 10.1513/AnnalsATS.201704-343OT.

57. Taccone P., Pesenti A., Latini R. et al. Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2009; 302 (18): 1977–1984. DOI: 10.1001/jama.2009.1614.

58. Guérin C., Reignier J., Richard J.C. et al. Prone positioning in severe acute respiratory distress syndrome. N. Engl. J. Med. 2013; 368 (23): 2159–2168. DOI: 10.1056/NEJMoa1214103.

59. Scaravilli V., Grasselli G., Castagna L. et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study. J. Crit. Care. 2015; 30 (6): 1390–1394. DOI: 10.1016/j.jcrc.2015.07.008.

60. Ding L., Wang L., Wanhong M., Hangyong H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit. Care. 2020; 24: 28. DOI: 10.1186/s13054-020-2738-5.

61. Pérez-Nieto O.R., Guerrero-Gutiérrez M.A., DeloyaTomas E., Ñamendys-Silva S.A. Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit. Care. 2020; 24: 114. DOI: 10.1186/s13054-020-2821-y.

62. Sun Q., Qiu H., Huang M., Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann. Intensive Care. 2020; 10 (1): 33. DOI: 10.1186/s13613-020-00650-2.

63. Sartini C., Tresoldi M., Scarpellini P. et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit. JAMA. 2020; May 15 (Published online). DOI: 10.1001/jama.2020.7861.

64. Elharrar X., Trigui Y., Dols A. et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA. 2020; May 15 (Pub - lished online). DOI: 10.1001/jama.2020.8255.

65. Kallet R.H. A comprehensive review of prone position in ARDS. Respir. Care. 2015; 60 (11): 1660–1687. DOI: 10.4187/respcare.04271.

66. Telias I., Katira B.H., Brochard L. Is the prone position helpful during spontaneous breathing in patients with COVID-19? JAMA. 2020; May 15 (Published online). DOI: 10.1001/jama.2020.8539.